The International Neuromodulation Society

The Fastest-Growing, Worldwide Multidisciplinary Body Devoted to Building Knowledge of Neuromodulation

The International Neuromodulation Society (INS) is a non-profit group of clinicians, scientists and engineers dedicated to the scientific development and awareness of neuromodulation – the alteration of nerve activity through targeted delivery of a stimulus, such as electrical stimulation or chemical agents, to specific neurological sites in the body. The San Francisco-based INS was formed in 1989 and educates and promotes the field through meetings, its peer-reviewed journal Neuromodulation: Technology at the Neural Interface, mentorship, and chapter websites. The INS also provides information for patients and produces rolling news briefs about this rapidly evolving field.

The INS Peer-Reviewed Journal

The INS journal Neuromodulation: Technology at the Neural Interface has a growing Impact Factor and is indexed in Index Medicus, MEDLINE and Pubmed from its first issue in 1998. Members may log in to the members-only section to read the journal online. The journal also has social media accounts on Twitter, Facebook, and Instagram.

journal cover

+Submit a Manuscript.+

What is Neuromodulation?

Medical Professionals can learn about various considerations concerning neuromodulation and clinic contacts. Once your preliminary questions have been answered, please use the Contact Us facility to find out more and to discuss specific objectives. Others may simply wish to join the INS and one of its related chapter societies, please use the Membership Application.

Clinical trials that involve a wide range of emerging neuromodulation approaches are listed on our Research page. Neuromodulation clinical trials address symptom control through nerve stimulation in such condition categories as:

If you are not a medical professional and you are searching for information about neuromodulation and how these types of treatment could benefit a specific condition such as treatment-resistant headache or other chronic pain syndromes, you may find the sections titled Therapies, About Neuromodulation or FAQs particularly helpful.

Members may log in and visit the members-only section’s Global Discussion Forum

Breaking News Share

Neurostimulation Company Prices Public Offering, Convertible Senior Notes, Totaling Over $300 Million

April 2, 2020 - Nevro Corp. is raising more than $300 million through a public offering and convertible senior notes. (Mass Device)

Noninvasive Neurostimulation Device Subject to an FDA Application for Emergency Use Authorization

April 2, 2020 - The company electroCore has submitted to the FDA an application for Emergency Use Authorization to facilitate study and clinical use of its gammaCore Sapphire noninvasive vagus nerve stimulation therapy for potential use to address respiratory symptoms associated with COVID-19. The application included non-clinical data and data from several pilot studies that involved patients with a variety of respiratory disorders. (Street Insider)

Researchers Document Effects of Target Variations in Circuit-Based Neuromodulation for Depression

April 1, 2020 - In a retrospective analysis transcranial magnetic stimulation to the dorsolateral prefrontal cortex for patients with depression, an article describes how small variations in stimulation location were investigated in order to potentially address different depression symptoms, such as sleep disruption, worry, and negative mood. (Science Translational Medicine)

Retrospective Review of Noninvasive Brain Stimulation After Onset of Vestibular Migraine

April 1, 2020 - A single-center retrospective review describes effects of external trigeminal stimulation after onset of vestibular migraine. (Physicians Weekly)

To see select neuromodulation news by category, as well as news about the INS in particular, please visit the Newsroom. To see archived news briefs dating back to January 2011, visit the News Archive.

Continue Reading News Briefs

International Neuromodulation Society 3rd Interim Meeting, Oct. 23-25, 2020, Mumbai, India:

Last Updated on Monday, December 12, 2016 10:01 AM